Finally, it will be highly interesting to study if second-generation tau-PET studies thatallow in vivo assessment of 4R-tau levels in PSP patients6,7 will demonstrate identical or differential pattern of subsequent involvementof brain structures in PSP. This evidence concerns the gene MAPT and supranuclear palsy, progressive, 1.